Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
13(81.3%)
Phase 2
2(12.5%)
Phase 3
1(6.3%)
16Total
N/A(13)
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT05193929Not ApplicableCompleted

A Clinical Investigation Evaluating Wound Closure With OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's

Role: collaborator

NCT06035523Not ApplicableCompleted

Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™

Role: collaborator

NCT06035536Not ApplicableCompleted

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Role: collaborator

NCT06319287Phase 2Completed

Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)

Role: collaborator

NCT06403605Not ApplicableCompleted

Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Role: collaborator

NCT06140303Phase 3Active Not Recruiting

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Role: collaborator

NCT06681428Not ApplicableRecruiting

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Role: collaborator

NCT04564443Not ApplicableActive Not Recruiting

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Role: collaborator

NCT05797285Not ApplicableCompleted

Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers

Role: collaborator

NCT05276401Phase 2Terminated

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Role: collaborator

NCT03398538Not ApplicableCompleted

Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Role: collaborator

NCT02331147Not ApplicableCompleted

Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers

Role: collaborator

NCT03881267Not ApplicableCompleted

SkinTE® in the Treatment of Venous Leg Wounds

Role: collaborator

NCT04040426Not ApplicableCompleted

Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

Role: lead

NCT02870816Not ApplicableCompleted

Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot Ulcers

Role: lead

NCT03881254Not ApplicableCompleted

SkinTE™ in the Treatment of Diabetic Foot Wounds

Role: collaborator

All 16 trials loaded